Marisol Cano

Dr. Marisol Cano


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
JHJames T Handa
James T Handa
MCMarisol Cano
Marisol Cano
LWLei Wang
Lei Wang
SDSayantan Datta
Sayantan Datta
TLTongyun Liu
Tongyun Liu

1 July 2014 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
LWLei Wang
Lei Wang
MCMarisol Cano
Marisol Cano
JHJames T Handa
James T Handa

1 May 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
LWLei Wang
Lei Wang
NKNaoshi Kondo
Naoshi Kondo
MCMarisol Cano
Marisol Cano
KEKatayoon Ebrahimi
Katayoon Ebrahimi
TYTakeshi Yoshida
Takeshi Yoshida
JHJames T Handa
James T Handa

25 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DZDavid N Zacks
David N Zacks
AKAndrew Joseph Kocab
Andrew Joseph Kocab
JCJoanne J. Choi
Joanne J. Choi
MGMeredith S. Gregory-Ksander
Meredith S. Gregory-Ksander
MCMarisol Cano
Marisol Cano
JHJames T Handa
James T Handa
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the developed world. While great advances have been made in the treatment of the neovascular (“wet”) form of the disease, there is still a significant need for therapies that prevent the vision loss associated with the advanced forms of dry, atrophic AMD. In this atrophic form, retinal pigment epithelial (RPE) and photoreceptor cell death is the ultimate cause of vision loss. In this review, we summarize the cell death pathways and their relation to RPE and retinal cell death in AMD. We review the data that support targeting programmed cell death through inhibition of the Fas receptor as a novel approach to preserve these structures and that this effect results from inhibiting both canonical death pathway activation and reducing the associated inflammatory response. These data lay the groundwork for current clinical strategies targeting the Fas pathway in this devastating disease.

2 October 2015
Verified
Book Chapter
Closed access
PDF file
LWLei Wang
Lei Wang
KEKatayoon B Ebrahimi
Katayoon B Ebrahimi
MCMichelle Chyn
Michelle Chyn
MCMarisol Cano
Marisol Cano
JHJames T Handa
James T Handa

28 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KSKrishna Singh
Krishna Singh
YJYang Jin
Yang Jin
MHMing-Wen Hu
Ming-Wen Hu
IPIsabella Palazzo
Isabella Palazzo
MCMarisol Cano
Marisol Cano
JHJames T Handa
James T Handa
Environmental exposure such as cigarette smoke induces epigenetic changes that can induce degenerative heterogeneity and accelerate aging. In early age-related macular degeneration (AMD), the leading worldwide cause of blindness among the elderly, retinal pigment epithelial (RPE) cell heterogeneity is a key change. Since smoking is the strongest environmental risk factor for AMD, we hypothesized that cigarette smoke induces degenerative RPE heterogeneity through epigenetic changes that are distinct from aging, and that with aging, the RPE becomes vulnerable to cigarette smoke insult. We administered cigarette smoke condensate (CSC) intravitreally to young and aged mice and performed snRNA-seq and snATAC-seq on the RPE/choroid. This analysis identified separate cell clusters corresponding to healthy and abnormal, dedifferentiated RPE in both aged vehicle-treated and young CSC-treated mice. The dedifferentiated RPE were characterized by a global decrease in chromatin accessibility and decreased expression of genes in functional categories that were linked to hallmarks of aging. Notably, young, dedifferentiated RPE also exhibited a compensatory upregulation of hallmarks of aging-related genes, specifically those related to mitochondrial function and proteostasis. In contrast, aged dedifferentiated RPE did not express these compensatory changes, and did not survive CSC treatment, as experimentally verified with TUNEL labeling. These changes are relevant to early AMD because we identified through scRNA-seq, similar dedifferentiated and healthy macular RPE clusters in a donor who smoked and another with early AMD, but not from a nonsmoker. Degenerative cellular heterogeneity can include an abnormal cluster that jeopardizes cell survival and may represent an additional hallmark of ocular aging.